Table 2.
Correlation between clinicopathological characteristics and pJNK expression in 483 gastric cancers
| pJNK | P | ||
|---|---|---|---|
| Positive (%) | Negative (%) | ||
| Total | 182 (38) | 301 (62) | |
| Age (years) | |||
| 0–39 | 13 (36) | 23 (64) | 0.432 |
| 40–65 | 103 (36) | 186 (64) | |
| 66–88 | 66 (42) | 92 (58) | |
| Gender | |||
| Male | 134 (40) | 203 (60) | 0.091 |
| Female | 48 (33) | 98 (67) | |
| Lauren’s classification | |||
| Intestinal | 104 (44) | 132 (56) | 0.037* |
| Diffuse | 62 (32) | 131 (68) | |
| Mixed | 16 (30) | 38 (70) | |
| pTNM stage | |||
| I | 127 (47) | 144 (53) | <0.001* |
| II | 22 (24) | 69 (76) | |
| III | 21 (34) | 41 (66) | |
| IV | 12 (20) | 47 (80) | |
| Lymphatic invasion | |||
| Absent | 113 (41) | 160 (59) | 0.034* |
| Present | 69 (33) | 141 (67) | |
pJNK phosphorylated c-Jun N-terminal kinase, TNM tumor-node metastasis
*Considered to be statistically significant (<0.05)